Search Ontology:
ChEBI

pazopanib hydrochloride

Term ID
CHEBI:71217
Synonyms
  • 5-((4-((2,3-Dimethyl-2H-indazol-6-yl)methylamino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochloride
  • 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide hydrochloride
  • GW786034B
  • pazopanib HCl
  • pazopanib monohydrochloride
  • Votrient
Definition
A hydrochloride salt prepared from equimolar amounts of pazopanib and hydrochloric acid. Used for treatment of kidney cancer.
References
  • cas:635702-64-6
  • kegg.drug:D05380
  • patent:US2008293691
  • patent:WO2005105094
  • patent:WO2006020564
  • patent:WO2007064753
  • patent:WO2007143483
  • patent:WO2009062658
  • patent:WO2011069053
  • patent:WO2011150044
  • pubmed:18040531
  • pubmed:19229381
  • pubmed:19365030
  • pubmed:19427156
  • pubmed:19798455
  • pubmed:19954277
  • pubmed:19967103
  • pubmed:20043026
  • pubmed:20189340
  • pubmed:20383346
  • pubmed:20407031
  • pubmed:20664824
  • pubmed:21225019
  • pubmed:21470066
  • pubmed:21995103
  • pubmed:22074946
  • pubmed:22341567
  • pubmed:22679111
  • pubmed:22984765
  • reaxys:11572612
  • wikipedia.en:Pazopanib_hydrochloride
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from pazopanib hydrochloride
Phenotype where environments contain pazopanib hydrochloride
Phenotype modified by environments containing pazopanib hydrochloride
Phenotype affecting pazopanib hydrochloride
Human Disease Model